Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 16, Number 3—March 2010
Dispatch

Increasing Skin Infections and Staphylococcus aureus Complications in Children, England, 1997–2006

Sonia SaxenaComments to Author , Paula Thompson, Ruthie Birger, Alex Bottle, Nikos Spyridis, Ian Wong, Alan P. Johnson, Ruth Gilbert, Mike Sharland, on behalf of improving Children’s Antibiotic Prescribing Group
Author affiliations: Imperial College London, London, UK (S. Saxena, R. Birger, A. Bottle); School of Pharmacy, London (P. Thompson, I. Wong); St. George's Hospital National Health Service Trust, London (N. Spyridis); Health Protection Agency, London (A.P. Johnson, M. Sharland); University College London Institute of Child Health, London (R. Gilbert)

Main Article

Table 1

Age- and sex-adjusted skin condition consultation and antibacterial drug prescribing rates for children <18 years of age, England, 1997–2006 *

Year Rate/1,000 child-years† (95% CI)
GP consultations for skin conditions Antibacterial drugs for skin conditions Flucloxacillin for skin conditions All flucloxacillin All antibacterial drugs
1997 128.52
(127.21–129.83) 59.53
(58.63–60.43) 17.76
(17.28–18.25) 35.04
(34.36–35.72) 541.42
(538.75–544.09)
1998 128.17
(126.87–129.47) 60.44
(59.54–61.34) 19.33
(18.83–19.84) 37.35
(36.65–38.05) 498.64
(496.09–501.20)
1999 135.91
(134.57–137.24) 65.68
(64.74–66.61) 24.39
(23.83–24.96) 44.03
(43.27–44.79) 438.24
(435.84–440.63)
2000 142.80
(141.44–144.17) 70.17
(69.21–71.13) 27.46
(26.86–28.06) 48.89
(48.09–49.69) 431.80
(429.42–434.18)
2001 146.75
(145.36–148.14) 73.43
(72.45–74.41) 30.65
(30.01–31.28) 52.76
(51.93–53.60) 460.68
(458.21–463.14)
2002 145.56
(144.17–146.94) 71.64
(70.68–72.61) 28.70
(28.09–29.32) 51.39
(50.56–52.21) 443.77
(441.34–446.19)
2003 154.81
(153.37–156.24) 75.69
(74.69–76.68) 31.39
(30.74–32.04) 56.00
(55.13–56.87) 459.94
(457.45–462.43)
2004 157.56
(156.07–159.05) 77.51
(76.47–78.55) 30.75
(30.09–31.42) 56.22
(55.32–57.12) 458.60
(456.04–461.16)
2005 156.05
(154.54–157.57) 75.98
(74.93–77.04) 27.32
(26.68–27.96) 53.58
(52.68–54.47) 489.24
(486.55–491.93)
2006
 152.94
(151.44–154.45)
 77.62
(76.54–78.69)
 29.13
(28.47–29.80)
 56.07
(55.15–56.99)
 484.30
(481.61–486.98)
p value‡ 0.011 0.005 0.001 0.001 0.005

*Data from International Marketing Systems Health. CI, confidence interval; GP, general practitioner.
†Directly age-sex adjusted to 2000 sample population.
‡p value test for linear trend across years.

Main Article

Page created: December 14, 2010
Page updated: December 14, 2010
Page reviewed: December 14, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external